Position in BVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$243,363
+$120,729 QoQ
Shares Held
25,780
+91.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 154 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. BVS ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
36,381 | $11,487,300 | |
| 2 | AVNS |
Avanos Medical, Inc.
|
115,133 | $2,864,509 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
2,015 | $591,624 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
19,002 | $286,740 | |
| 5 | DXCM |
Dexcom Inc
|
3,857 | $259,768 | |
| 6 | RXST |
RxSight, Inc.
|
51,600 | $248,712 | |
| 7 | BVS |
Bioventus Inc.
This page
|
25,780 | $243,363 | |
| 8 | VREX |
Varex Imaging Corp
|
23,254 | $242,539 |
All Filings in BVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $243,363 | 25,780 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $122,634 | 13,432 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $127,596 | 17,150 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $73,523 | 10,990 | Shares | Other | 2025-11-14 | |
| 2025-03-31 | $182,231 | 19,916 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $191,457 | 18,234 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $322,542 | 26,991 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||